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The evolutionarily ancient arm of the E2f family of
transcription factors consisting of the two atypical
members E2f7 and E2f8 is essential for murine
embryonic development. However, the critical
tissues, cellular processes, and molecular pathways
regulated by these two factors remain unknown.
Using a series of fetal and placental lineage-specific
cremice, we show that E2F7/E2F8 functions in extra-
embryonic trophoblast lineages are both necessary
and sufficient to carry fetuses to term. Expression
profiling and biochemical approaches exposed the
canonical E2F3a activator as a key family member
that antagonizes E2F7/E2F8 functions. Remarkably,
the concomitant loss of E2f3a normalized placental
gene expression programs, corrected placental
defects, and fostered the survival of E2f7/E2f8-
deficient embryos to birth. In summary, we identified
a placental transcriptional network tightly coordi-
nated by activation and repression through two
distinct arms of the E2F family that is essential for
extraembryonic cell proliferation, placental develop-
ment, and fetal viability.
INTRODUCTION
Cells respond to external growth stimuli by activating signaling
cascades that carry them through the cell cycle to generate
two genetically identical daughter cells. A critical step in these
proliferative signaling cascades involves the activation of G1-
specific cyclin-dependent kinases (Cdks), the phosphorylation
of retinoblastoma (Rb) and Rb-related pocket proteins, and the
accumulation of E2F transcriptional activity (Frolov and Dyson,Deve2004). The execution of E2F-dependent transcription late in the
G1 phase is believed to be the final event in Cdk-mediated mito-
genic signaling that commits cells to S phase entry. Subsequent
waves of E2F-mediated repression are thought to coordinate
the completion of the remaining phase-specific events and
successful cell divisions. This classic paradigm of E2F-mediated
gene activation and repression in the control of cell-cycle pro-
gression is based almost exclusively on the analyses of inverte-
brates and overexpression strategies in mammalian cell-culture
systems (Dimova andDyson, 2005; Frolov et al., 2001). However,
analyses of mice deficient for various E2F family members have
revealed a spectrum of tissue-specific phenotypes that are
inconsistent with the rigid view of E2Fs as universal factors
required to coordinate cell-cycle-dependent gene-expression
programs (Chen et al., 2009; Chong et al., 2009b; Cloud et al.,
2002; Danielian et al., 2008; Field et al., 1996; Humbert et al.,
2000; Kinross et al., 2006; Li et al., 2003, 2008; Lindeman
et al., 1998; Murga et al., 2001; Pohlers et al., 2005; Rempel
et al., 2000; Tsai et al., 2008; Yamasaki et al., 1996). These find-
ings suggest that E2F family members either have different
functions or perform similar functions but in a tissue-specific
manner. It is also possible that the ablation of individual family
members is insufficient to expose how their combined activities
might be coordinated in vivo.
The E2F family consists of nine related proteins (DeGregori
and Johnson, 2006) that, based on sequence conservation
and structure-function studies, have been conveniently divided
into transcription activators and repressors. Canonical E2F
activators, consisting of E2F1, E2F2, E2F3a, and E2F3b, have
transactivation domains and associate with coactivator proteins
to robustly induce RNA polymerase II-dependent gene expres-
sion (Danielian et al., 2008; Trimarchi and Lees, 2002). E2F
repressors fall into two subclasses, with E2F4, E2F5, and E2F6
in one subclass (canonical) and E2F7 and E2F8 in the other
(atypical). While repression mediated by E2F4–E2F6 is respon-
sive to Cdk signaling and involves the recruitment of histone
deacetylases (HDACs), polycomb group proteins, Mga andlopmental Cell 22, 849–862, April 17, 2012 ª2012 Elsevier Inc. 849
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E2F8 mediate repression is essentially unknown but appears
to be independent of Cdk-mediated phosphorylation of pocket
proteins. To make matters more complex, it is now clear that in
at least some developmental contexts, E2F activators can also
function to repress gene expression, but the molecular basis
for such plasticity is not completely understood (Chen et al.,
2009; Chong et al., 2009b; Trikha et al., 2011; Wenzel et al.,
2011).
Unlike other E2F family members, E2F7/E2F8 associate with
DNA independent of dimerization with DP1/DP2 proteins, and
instead utilize two tandem DNA-binding domains to recognize
and bind target DNA sequences. These two atypical E2Fs also
lack amino acid sequences typically used to physically interact
with Rb-related proteins, and thus may function outside the
canonical Cdk-Rb-E2F pathway. Previous work showed that
embryos lacking E2f7 and E2f8 exhibit widespread apoptosis
and die by E11.5 (Li et al., 2008). In the current study, we
developed extraembryonic lineage-specific cre mice to explore
E2F7/E2F8 functions during development. Usingmouse genetic,
biochemical, and bioinformatic approaches we identified two
antagonistic arms of the E2F program, one regulated by E2F7/
E2F8 and the second by E2F3a, that coordinate the G1-S
transcriptional output necessary for balancing cell proliferation
and differentiation in the placenta. Ablation of the repressive
E2F7/E2F8arm in trophoblast cell lineageswas sufficient to incite
ectopic proliferation and disrupt placental architecture and
function, which inevitably led to embryonic death by E11.5.
Remarkably, many of the phenotypes observed in E2f7/;
E2f8/ embryos, including their early lethality, were suppressed
by theconcomitant ablation of theE2f3aactivator. These findings
provide a mechanism for how canonical and atypical E2F
pathways coordinate the control of transcriptional programs
essential for mammalian cell proliferation and development.
RESULTS
Loss of E2f7 and E2f8 Leads to Profound Placental
Defects
Previous studies using gene knockout approaches in mice
showed that E2F7 and E2F8 are essential for embryonic
development, but the tissues, cellular processes, and molecular
pathways that they regulate are poorly defined (Li et al., 2008).
We reasoned that identification of the tissues and cells where
E2F7 and E2F8 functions are most critical for embryonic devel-
opment and viability might provide valuable insight into their
physiological function. Expression analysis demonstrated that
E2f7 and E2f8mRNA levels are relatively high in placental versus
fetal tissues (Figure 1A), with peak expression at E10.5
(Figure 1B). Interestingly, a second wave of placental E2f8
expression coincided with the proliferation of glycogen tropho-
blast cells at E15.5 (Coan et al., 2006). Immunohistochemistry
(IHC) on placental sections showed E2F7 and E2F8 proteins in
the three major trophoblast lineages, labyrinth trophoblasts
(LTs), spongiotrophoblasts (STs), and trophoblast giant cells
(TGCs) (Figure 1C). The observation that E2F7 and E2F8 proteins
were highly expressed in some cells but undetectable in others
likely reflects their cell-cycle-dependent expression (de Bruin
et al., 2003; Di Stefano et al., 2003; Maiti et al., 2005).850 Developmental Cell 22, 849–862, April 17, 2012 ª2012 Elsevier IThe above findings prompted us to examine placentas of
E2f7/;E2f8/ embryos. Histological examination of double-
mutant placentas revealed severely compromised tissue archi-
tecture (Figure 1D, right panels). Wild-type placentas typically
have a well organized labyrinth of trophoblast cells, with the
vasculature arranged as a network of maternal sinusoids juxta-
posed to fetal-derived blood vessels (Figure 1D, left panels). In
contrast, E2f7/;E2f8/ placentas were overall smaller and
had abnormally large clusters of densely packed trophoblast
cells that failed to effectively invade into the maternal decidua.
The vascular networkwas poorly formed, andmaternal sinusoids
were rarely found adjacent to fetal blood vessels. DNA replication
and mitotic markers were elevated in mutant STs and TGCs, as
determined by IHC using anti-BrdU and anti-phopho-histone3
antibodies (Figure 1E, top two rows; Figure S1A available online).
An increased number of apoptotic STs was also observed in
doublemutant placentas (Figures 1E, lower row, andS1A).More-
over, quantitative reverse transcriptase polymerase chain
reaction (qRT-PCR) analysis showed that double-mutant
placentas have normal expression of trophoblast stem (TS)
cell-specific markers (Eomes and Cdx2) but reduced levels of
ST- and TGC-specific markers (Tpbp, Pdgf and Proliferin,
Csf1r, Pl-1, and Prp, respectively; Figures 1F and S1B). In situ
hybridization confirmed lower expression of Tpbp and Proliferin
in mutant STs and TGCs, respectively, and IHC showed lower
levels of Esx1 and PL-1 proteins in mutant LTs and TGCs,
respectively (Figure 1G). Therefore, in addition to the fetal
defects previously characterized (Li et al., 2008),E2f7/;E2f8/
embryos exhibit a severely compromised placenta that is
associated with ectopic proliferation, apoptosis, and altered
differentiation of multiple extraembryonic cell lineages.
Loss of E2f7 and E2f8 Disrupts a Distinct Gene
Expression Program in the Placenta
We reasoned that changes in gene expression would directly
underlie many of the phenotypes caused by loss of the two atyp-
ical E2F transcription factors. We thus performed global gene
expression profiling (Affymetrix Mouse Genome 430 2.0) in
wild-type and double mutant E10.5 placentas and fetuses.
Unsupervised clustering analysis of gene expression separated
samples into two groups, with fetuses clustering in one group
and placentas clustering in the other (Figure 2A). Samples within
each group could be further clustered based on the genotype of
the tissue. Heat maps illustrate that most differentially expressed
genes in double-mutant placentas are distinct from those in
mutant fetuses (Figure 2B). For example, expression of many
E2F target genes, as identified by previous gene-expression,
reporter, and chromatin immunoprecipitation (ChIP) assays,
was significantly increased in double-mutant placentas but not
in mutant fetuses (Figure 2C). On the other hand, there was
a significant increase in the expression of genes related to
nutritional and hypoxic stress responses in mutant fetuses but
not in mutant placentas, including a marked induction of
HIF-1a targets (Figure 2D and Table S1).
E2F7 and E2F8 Functions Are Essential in Trophoblast
Progenitor Cells
The above findings led us to hypothesize that a primary defect in
E2F-target expression in mutant placentas may lead to placentalnc.
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Figure 1. Profound Placental Defects in
E2f7–/–E2f8–/– Embryos
(A) Quantitative RT-PCR analysis of E2f7 and E2f8
expression in E10.5 wild-type placentas (gray) and
fetuses (white).
(B) Quantitative RT-PCR analysis of E2f7 (gray) and
E2f8 (black) expression in wild-type placentas at
different stages of embryonic development.
(C) E2F7 (top) and E2F8 (bottom) protein expression
as identified by IHC in E10.5 placental sections with
the indicated genotypes.
(D) H&E of E10.5 placental sections. Bottom panels
are high-magnification views of representative
boxed areas in top panels.
(E) Quantification of BrdU, TUNEL, and P-H3-
positive trophoblast cells in E10.5 E2f7+/+E2f8+/+
(black) and E2f7/E2f8/ (red) placentas (**p <
0.01). TGC, trophoblast giant cells; ST, spongio-
trophoblasts; LT, labrynthine trophoblasts.
(F) Quantitative RT-PCR analysis for trophoblast
lineage markers in E10.5 E2f7+/+E2f8+/+ (black) and
E2f7/E2f8/ (red) placentas.
(G) Qualitative analysis of differentiation markers
in major trophoblast lineages in placentas. Top:
representative IHC analysis of LT-specific Esx1
immunohistochemistry staining (E10.5). Middle
panels: RNA in situ hybridization analysis of ST-
specific Tpbp (E10.5) and TGC-specific Proliferin
(E9.5). Bottom: immunofluorescent detection of
TGC-specific Placental Lactogen 1 (E10.5). For (A),
(B), (E) and (F), data are reported as average ± SD.
Scale bars, 100 mm. Yellow dotted line demarks
junctional zone from decidua. De., Decidua; La.,
Labyrinth.
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E2F Activation and Repression in Developmentdysfunction and underlie the profound stress response, fetal
growth retardation, and midgestation lethality observed in
E2f7/;E2f8/ embryos. To test this possibility we assessed
the consequences of ablating E2f7 and E2f8 in either placental
or fetal compartments to the overall development of embryos.
First, we analyzed the consequences of ablating E2f7 and E2f8
in specific extraembryonic cell lineages. Our initial focus wasDevelopmental Cell 22, 849on STs and TGCs, since dramatic defects
in these cell types were observed in
E2f7/;E2f8/ placentas (Figures 1E–
1G). To this end, Tpbp-cre transgenic
mice were used to target gene deletion in
STs (Simmons et al., 2007). We also gener-
ated and used Plf cre/+ and Pl1cre/+ knockin
mice to target cre-mediated recombination
in TGCs (Figure 3A; unpublished data).
Ablation of E2f7 and E2f8 in either or both
of these cell lineages (ST and TGC) resulted
in live and phenotypically normal fetuses at
every embryonic stage analyzed, including
at birth (Figures 3B and 3D; data not
shown). Placentas appeared well vascular-
ized without any evidence of architectural
disruption (Figure 3D). The specific abla-
tion of E2f7 and E2f8 in STs and TGCs
was confirmed by laser-capture microdis-section (LCM) of the appropriate extraembryonic cell lineages
and PCR genotyping (Figure 3C). To ablate these E2fs in the
entire placenta, we interbred E2f7loxp/loxp;E2f8loxp/loxp and
Cyp19-cre mice, which express cre in all trophoblast cells,
including in undifferentiated trophoblast progenitor cells as early
as E6.5 (Wenzel and Leone, 2007). Strikingly, these intercrosses
failed to yield any live Cyp19-cre;E2f7loxp/loxp;E2f8loxp/loxp–862, April 17, 2012 ª2012 Elsevier Inc. 851
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Figure 2. Loss of E2f7 and E2f8 in the Placenta Elicits an Intense
Stress Response in the Fetus
(A) Dendrogram of unsupervised hierarchical clustering analysis of E10.5
fetal and placental global gene-expression profiles using centered correlation
and average linkage.
(B) Heat maps of microarray probes that showed a >2-fold misregulation
in E2f7/;E2f8/ fetuses or placentas relative to their E2f7+/+;E2f8+/+ coun-
terparts (p < 0.05). n, number of samples analyzed per genetic group.
(C) Scatterplot analyses of E2F target gene expression in fetuses and
placentas of indicated genotypes using 1.5-fold cutoff (red, >1.5-fold
deregulation).
(D) Scatterplot analyses of stress-related gene expression in fetuses
and placentas of indicated genotypes using 2-fold cutoff (red, >2-fold
deregulation).
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E2F Activation and Repression in Developmentembryos past E10.5 (Figure 3B). Gross and histological examina-
tion of live E10.5 Cyp19-cre;E2f7loxp/loxp;E2f8loxp/loxp embryos
revealed a similar collapse of the labyrinth-like placental archi-
tecture along with vascular dilation, hemorrhage, and growth852 Developmental Cell 22, 849–862, April 17, 2012 ª2012 Elsevier Iretardation in associated fetuses (with intact E2f7 and E2f8),
as observed in E2f7/;E2f8/ embryos (Figures 3D, S2A,
and S2B).
To determine whether fetal functions of E2F7 and E2F8
are also required for embryonic development, E2f7loxp/loxp;
E2f8loxp/loxp and Sox2-cre;E2f7+/;E2f8+/ mice were interbred
and their progeny analyzed at various stages of embryonic and
postnatal development. Transgenic Sox2-cre mice express cre
in all cells of the inner cell mass (embryo proper) with no expres-
sion in the trophoblast or extraembryonic lineages (Hayashi
et al., 2002). From these intercrosses we recovered live
Sox2-cre;E2f7loxp/-;E2f8loxp/- fetuses at every embryonic stage
analyzed, including at birth (P0), althoughmost of these newborn
pups died within their first day of life (Figures 4A and S3C).
The specific deletion of E2f7 and E2f8 in fetal tissues was
confirmed by PCR genotyping and X-Gal staining of Sox2-
cre;E2f7loxp/-;E2f8loxp/-;Rosa26+/loxp embryonic tissues (Figures
4B, S3A, and S3B). Double-mutant E10.5 fetuses supplied with
a wild-type placenta (Sox2-cre;E2f7loxp/-;E2f8loxp/-) appeared
normal and lacked the severe developmental phenotypes
characteristic of E10.5 E2f7/;E2f8/ embryos (Figure 4C).
Together, these data suggest that the disruption of E2f7
and E2f8 in trophoblast progenitor cells is most likely the defin-
ing event causing midgestation lethality of E2f7/;E2f8/
embryos. From these genetic analyses, we conclude that
extraembryonic functions of E2f7 and E2f8 are necessary and
sufficient for embryonic development.
Identification of E2F7 and E2F8 Target Genes
In an attempt to reveal the molecular events regulated by
E2f7 and E2f8 we compared gene-expression profiles in E10.5
placentas derived from four genetic groups, E2f7+/+;E2f8+/+,
E2f7/;E2f8/, Cyp19-cre;E2f7loxp/loxp;E2f8loxp/loxp, and Sox2-
cre;E2f7loxp/-;E2f8loxp/-. As expected, unsupervised clustering
of gene expression separated the four placental cohorts into
two groups based on the presence or absence of E2F7/E2F8
proteins, with placentas from E2f7+/+;E2f8+/+ and Sox2-cre
cohorts clustering together in one group (Group I), and doubly
deficient placentas from E2f7/;E2f8/ andCyp19-cre cohorts
clustering in the other (Group II) (Figure 5A). The heat maps
and scatter plots shown in Figures 5B–5D further highlight
the similar expression profiles between E2f7/;E2f8/ and
Cyp19-cre placentas and between E2f7+/+;E2f8+/+ and Sox2-
cre placentas.
Given the known roles of E2F7 and E2F8 in transcriptional
repression, we focused on the analysis of upregulated genes
in placentas lacking E2f7/E2f8. The Venn diagram shown in
Figure 5E depicts the overlap of genes upregulated in E2f7/;
E2f8/ and Cyp19-cre;E2f7loxp/loxp;E2f8loxp/loxp placentas (p >
0.05 and > 2-fold). Querying the TFsearch engine revealed that
16 out of the 49 promoters derepressed in E2f7/E2f8-deficient
placentas contain consensus E2F binding sites that are
conserved between mouse and human (Figure 5E; Tables S3
and S4). Most of these 16 potential targets encode proteins
with functions related to the control of G1-S-specific events,
whereas derepressed targets lacking canonical E2F binding
sites encode proteins known to be associated with metabolic
and placental processes (Figure 5F; Table S3). Although ChIP
studies of E2F7/8 target genes have been performed in humannc.
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ChIP-grade in mouse cells. As a preliminary means of validating
candidate E2F7/8 target genes, we overexpressed flag-tagged
versions of E2F7 and E2F8 in human embryonic kidney cells
(HEK293) and performed ChIP assays using anti-flag antibodies.
These assays showed that anti-flag, but not control IgG anti-
bodies, could coimmunoprecipitate promoter sequences of
most of the 16 genes with E2F binding elements, but could not
coimmunoprecipitate irrelevant sequences lacking E2F binding
sites (downstream (ds) extronic sequences of E2f1 and Tubulin
(Tub)) (Figure 5G). Moreover, parallel ChIP assays with HEK293
cells expressing mutant versions of E2F7 and E2F8 lacking
DNA-binding capacity confirmed the specificity of these assays
(Figure 5G). From these results we conclude that many of the
placental E2F target genes containing E2F binding sites in their
promoters identified here by expression profiling represent
good candidate targets of E2F7 and E2F8. Whether targets lack-
ing canonical E2F bindings may be directly regulated by E2F7/
E2F8, as it would appear for E2F1 (Cao et al., 2011; Rabinovich
et al., 2008), remains to be determined.
Non-Cell-Autonomous Functions of E2F7 and E2F8 in
the Placenta Dictate Molecular Events in the Fetus
We then evaluated the extent to which E2F7 and E2F8 in the
placenta influences gene expression in fetal tissues. Once again,
unsupervised clustering analysis of E10.5 fetal expression
profiles derived from E2f7+/+;E2f8+/+, E2f7/;E2f8/, Cyp19-
cre;E2f7loxp/loxp;E2f8loxp/loxp, and Sox2-cre;E2f7loxp/-;E2f8loxp/-
embryos separated samples into two groups, with E2f7+/+;
E2f8+/+ and Sox2-cre;E2f7loxp/-;E2f8loxp/- fetuses clustering in
one group (Group I) and E2f7/;E2f8/ and Cyp19-cre;
E2f7loxp/loxp;E2f8loxp/loxp fetuses clustering in the other (Group
II) (Figure 6A). This clustering is remarkable given that samples
within each of the two groups represent fetuses that have oppo-
site genotypes. The common feature among samples within
each group is the presence (Group I) or absence (Group II) of
E2F7/E2F8 proteins in their associated placentas.
Consistent with these observations, the marked over-
representation of genes related to nutritional and hypoxic
stress responses (42 of 88 highly upregulated genes) in
E2f7/;E2f8/ embryos was almost completely alleviated in
E2f7/E2f8-deficient fetuses supplied with a wild-type placenta
(Sox2-cre;E2f7loxp/-;E2f8loxp/-). Conversely, loss of E2f7 and
E2f8 in the placenta (Cyp19-cre;E2f7loxp/loxp;E2f8loxp/loxp) was
sufficient to drive the expression of stress-related programs in
otherwise wild-type fetuses, highlighting the fact that the vast
majority of molecular and cellular events in double-mutant
fetuses are an indirect consequence to placental defects
(Figures 6B, 6C, and S4A).
E2F7 and E2F8 functions in the placenta also contribute to the
massive programmed cell death observed in E2f7/;E2f8/
fetuses. In contrast to E2f7/;E2f8/ fetuses, where apoptosis
is rampant in all tissues examined, TUNEL assays identified few
apoptotic cells in head regions and a moderate but significant
number of apoptotic cells in the branchial arch and somites of
either Sox2-cre;E2f7loxp/-;E2f8loxp/- or Cyp19-cre;E2f7loxp/loxp;
E2f8loxp/loxp fetuses (Figure 6D). While these data clearly
demonstrate that placental failure strongly contributes to pro-
grammed cell death in associated fetuses, they also identifyDevecell autonomous functions of E2F7 and E2F8 that promote cell
survival.
As described in Figure 4, supplying a wild-type placenta to
E2f7/E2f8-deficient fetuses (Sox2-cre;E2f7loxp/-;E2f8loxp/-)
carried embryos to term, but these rescued pups inevitably
died within a few days of life. Examination of organs in 1-day-
old Sox2-cre rescued pups revealed significant ectopic prolifer-
ation and apoptosis of pulmonary epithelial cells, which was
confirmed by TTF-1- and CC10-specific immunofluorescence
(IF) to represent Clara cells (bronchioles) (Figures S3D–S3F).
While the hypercellularity of pulmonary cells was obvious upon
visual inspection of H&E stained lung sections (Figure S3G),
other organs did not appear overtly hyperplastic (data not
shown). Based on these observations, we propose that prolifer-
ative imbalances leading to the cellular crowding of airways,
defective pulmonary function, lung collapse, and asphyxiation
may be themajor cause of lethality in Sox2-cre rescued newborn
pups, but further studies are needed to fully evaluate this and
other possibilities.
Loss of E2f3a Rescued Placental Defects and Lethality
of E2f7–/–;E2f8–/– Fetuses
We then considered potential mechanisms for how E2F7 and
E2F8 might regulate gene expression. The observation that
E2F target genes are upregulated in tissues lacking E2f7 and
E2f8 suggested a simple mechanism involving transcriptional
repression. However, it remained possible that other E2Fs could
participate in regulating the same target genes, particularly in the
absence of E2F7 and E2F8 function. Indeed, recent gene
knockout studies of E2F family members in mice have revealed
incredible cooperation, redundancy and cross-regulation among
E2F family members (Chen et al., 2009; Chong et al., 2009b;
Li et al., 2008; Trikha et al., 2011; Tsai et al., 2008).
Given the established role for E2F3a in extraembryonic tissues
(Chong et al., 2009a), we explored the functional relationship
between E2F7/E2F8 and E2F3a in placental development.
Quantitative RT-PCR and western blot assays showed that the
levels of E2f3a mRNA and its protein product were not altered
in E2f7/E2f8/ placental tissues (Figure 7A), suggesting that
E2f3a is unlikely to be a direct target of E2F7/E2F8-mediated
repression. Moreover, ChIP assays demonstrated significant
occupancy of E2F3a on E2F7/E2F8 target promoters, which
was not affected by the absence of E2f7 and E2f8 (Figure 7B,
red bars). We then entertained the possibility that E2F3a and
E2F7/E2F8 may act in parallel to regulate the expression of
target promoters and thus analyzed gene-expression profiles
in E2f3a/ animals. Remarkably, >90% of targets differentially
expressed in E2f7/E2f8-deficient tissues were also differentially
expressed in E2f3a-deficient tissues, but in the opposite direc-
tion (Figure 7C and S5A), suggesting that E2F3a and E2F7/
E2F8 activate and repress, respectively, an overlapping set of
targets.
To rigorously test the hypothesis that E2F3a and E2F7/E2F8
represent two antagonistic arms of the same E2F program, we
interbred E2f7+/;E2f8+/ and E2f3a/ animals and analyzed
gene expression in the resulting progeny. Surprisingly, expres-
sion profiling showed that a significant number of differentially
expressed genes shared between E2f7/E2f8 doubly deficient
and E2f3a-deficient E10.5 placentas, including most E2F targetlopmental Cell 22, 849–862, April 17, 2012 ª2012 Elsevier Inc. 853
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Figure 3. Extraembryonic Functions of E2F7 and E2F8 Are Essential for Embryonic Survival
(A) X-gal staining showing lineage specific expression of cre recombinase in Tpbp-cre, Plf cre/+ and Pl1cre/+ mice heterozygous for Rosa26loxp reporter allele.
(B) Genotypic analysis of embryos derived from intercrosses of Tpbp-cre, Plf cre, Pl1cre, and Cyp19-cre with E2f7loxp/loxp;E2f8loxp/loxp mice. For the Tpbp-cre,
Pl1cre, and Plf cre experiment, cre refers to the presence of cre allele in heterozygosity.
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Figure 4. Loss of E2f7 and E2f8 in the Embryonic
Compartment Is Compatible with Intrauterine Life
of the Fetus
(A) Genotypic analysis of embryos derived from inter-
crosses of E2f7loxp/loxp;E2f8loxp/loxp and Sox2-cre;E2f7+/;
E2f8+/ mice.
(B) Representative PCR genotyping analyses of E2f7 and
E2f8 in different organs of Sox2-cre; E2f7loxp/-;E2f8loxp/- P0
pups. T, tail; B, bladder; I, intestine; S, stomach; H, heart;
L, liver; K, kidney; Ln, lung; Br, brain; M, muscle; P,
placenta.
(C) Representative low- and high-magnification images of
H&E-stained E10.5 placental sections (top two rows) and
gross appearance of associated fetuses (bottom) with
the indicated genotypes. Note that wild-type and double-
mutant controls are shown for comparison. Arrows
indicate dilated vasculatures and hemorrhagic areas.
H&E scale bars, 100 mm; whole-mount scale bars, 1 mm.
De., Decidua; La., Labyrinth. Yellow dotted line demarks
junctional zone from decidua.
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E2F Activation and Repression in Developmentgenes, were expressed to normal or near-normal levels in triple-
deficient embryos (Figures 7C and S5B). The waterfall plot in Fig-
ure 7D depicts the extent to which loss of E2f3a normalizes the
expression of 285 gene targets, with some targets being
completely rescued (Class I), others partially rescued (Class II),(C) Representative PCR genotyping analyses of E2f7 and E2f8. Genomic DNA was isolated from E1
spongiotrophoblasts (ST) or giant cells (TGC) in Cyp19-cre;E2f7loxp/loxp;E2f8loxp/loxp (Cyp19-cre), T
E2f7loxp/loxp;E2f8loxp/loxp (Plf cre/+), respectively, along with cre negative controls (con) and whole fetu
(D) Representative low- and high-magnification images of H&E-stained E10.5 placental sections (to
(bottom) with the indicated genotypes. Arrows indicate dilated blood vessels and hemorrhagic area
1 mm. De., Decidua; La., Labyrinth. Yellow dotted line demarks junctional zone from decidua.
Developmental Cell 22and a small subset not rescued at all (Class III).
Quantitative RT-PCR confirmed the complete
or partial rescue of gene expression to wild-
type levels (Figure 7E). We interpret these
results to mean that the high levels of E2F target
genes observed in E2f7/E2f8 doubly deficient
cells is due to the additive effects of derepres-
sion and E2F3a-mediated activation.
Interestingly, loss of E2f3a led to downregula-
tion of E2f7 and E2f8 mRNA levels, suggesting
that E2F3a may directly activate the expression
of these two atypical repressors (Figure 7F).
Indeed previous work has demonstrated that
E2f7/E2f8 expression is regulated by E2F
binding sites in their promoters (de Bruin et al.,
2003; Maiti et al., 2005). These results suggest
that E2F3a-mediated accumulation of E2F7/
E2F8 proteins later in the S phase coordinates
the timely activation and repression of E2F
targets during the cell cycle. This coordinated
control of E2F target expression by E2F3a
and E2F7/E2F8 is of biological importance
because loss of E2f3a significantly suppressed
the ectopic DNA replication caused by a defi-
ciency in E2f7 and E2f8 (Figure 7G). Indeed,
E2f7/;E2f8/;E2f3a/ placentas appeared
normal, with well-organized labyrinthine archi-tecture and vasculature (Figure 7H). These placentas were
apparently functional, since associated fetuses lacked any signs
of an acute stress response and had no evidence of ectopic
programmed cell death (Figures 7I and 7J). Remarkably, we
were able to recover live E2f7/;E2f8/;E2f3a/ embryos at0.5 whole placentas (Pla) or laser-capture microdissected
pbp-cre;E2f7loxp/loxp;E2f8loxp/loxp (Tpbp-cre), and Plf cre/+;
ses (Fet).
p two rows) and gross appearance of associated fetuses
s. Histology scale bars, 100 mm; whole-mount scale bars,
, 849–862, April 17, 2012 ª2012 Elsevier Inc. 855
C-5.0                0.0              +5.0
p<0.05
Sox2 Cyp197
+/+
8
+/+
7
-/-
8
-/-
n=2 n=4 n=4 n=3
PlacentasB
E
A
Placenta-related gene expression
12
10
8
6
4
2 12108642
7
-
/
-
8
-
/
-
7
-
/
-
8
-
/
-
7
+/+
8
+/+
Cyp19R
el
at
ive
 e
xp
re
ss
io
n 
(lo
g 2
)
Relative expression (log 2)
12
10
8
6
4
2
108642
Relative expression (log 2)
7
-
/-
8
-
/-
7
+
/
+
8
+
/
+
7
-
/-
8
-
/
-
7
-
/-
8
-
/-
7
-
/
-
8
-
/-
7
+
/
+
8
+
/
+
S
o
x
2
S
o
x
2
S
o
x
2
S
o
x
2
1.0-
0.8-
0.6-
0.4-
0.2-
0.0-
-0.2-
Co
rre
la
tio
n
Placentas
C
y
p
1
9
C
y
p
1
9
C
y
p
1
9
D
G
12
E2F target gene expression
12
10
8
6
4
2
7
-
/
-
8
-
/
-
7
+/+
8
+/+
14
S
o
x
2
7
+/+
8
+/+
R
el
a
tiv
e
 e
xp
re
ss
io
n 
(lo
g 2
)
Relative expression (log 2) Relative expression (log 2)
12108642 14
12
10
8
6
4
2
14
12108642 14
113
49
25
Cyp19
(placenta)
7
-/-
8
-/-
(placenta)
33
16
-1000 +300
-1000 +300
E2F
G
1
/S G
2
/M
63% 5% 32%
DNA 
repair
Metabolism
Cell Cycle
7%
Placental
Other
22%
32%
39%
F
Placentas Placentas Placentas Placentas
Group I Group II
%
 o
f t
ot
al
 
in
pu
t
0
1
2
3
4
0
1
2
3
4
%
 o
f t
ot
al
 in
pu
t
0.00 -
0.01 -
0.02 -
0.03 -
0.04 -
0.05 -
0.06 -
0
5
0
5
0
5
0
5
0
2
4
6
8
0
2
0.00 -
0.01 -
0.02 -
0.03 -
0.04 -
0.05 -
0.06 -
Mcm5 TubMcm4 Ung E2f1dsZfp367
Mcm5 TubMcm4 Ung E2f1dsZfp367
F Ig F F Ig F F Ig F F Ig F F Ig FF Ig F
wt m wt m wt m wt m wt m wt mflag-E2F7:
ChIP:
F Ig F F Ig F F Ig F F Ig F F Ig FF Ig F
wt m wt m wt m wt m wt m wt mflag-E2F8:
ChIP:
Figure 5. Sox2-cre Fetuses and Cyp19-cre Placentas Recapitulate Molecular Events in Their Germline-Deleted Counterparts
(A) Dendrogram of unsupervised hierarchical clustering analysis of gene expression from E10.5 placentas with the indicated genotypes. Note the segregation
of placentas based on the genotypes. Sox2,Sox2-cre;E2f7loxp/-;E2f8loxp/-, Cyp19, Cyp19-cre;E2f7loxp/loxp;E2f8loxp/loxp, 7/;8/, E2f7/;E2f8/, 7+/+;8+/+,
E2f7+/+;E2f8+/+.
(B) Heat maps of genes with >2-fold misregulation in Cyp19, Sox2, or E2f7/;E2f8/ placentas relative to E2f7+/+;E2f8+/+ placentas (p < 0.05). n, number of
placentas analyzed per genetic group.
(C) Scatterplot analyses of placenta-related gene expression in placentas with indicated genotypes using a 2-fold cutoff (red, >2-fold deregulation).
(D) Scatterplot analyses of E2F target gene expression in placentas with indicated genotypes using a 1.5-fold cutoff (red, >1.5-fold deregulation).
(E) Venn diagram depicting the overlap in genes significantly upregulated (>2-fold, p < 0.05) in E2f7/E2f8/ and Cyp19 placentas (left). Schematic diagram
of two types of representative promoters are depicted on the right (1000 bp to +300 bp relative to transcriptional start site) of the 49 genes shared between
two placental sets. Of 49 promoters, 16 have at least one E2F binding site conserved between mice and humans.
(F) Gene ontology of the 49 overlapping genes in E.
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Figure 6. Cell-Autonomous and Non-Cell-Autonomous Functions of E2f7 and E2f8 in the Fetus
(A) Dendrogram of unsupervised hierarchical clustering analysis of gene expression from E10.5 fetuses with the indicated genotypes. Note that the segregation of
these fetuses is based on the genotype of their placentas. Sox2, Sox2-cre;E2f7loxp/-;E2f8loxp/-, Cyp19, Cyp19-cre;E2f7loxp/loxp;E2f8loxp/loxp, 7/;8/,
E2f7/;E2f8/, 7+/+;8+/+, E2f7+/+;E2f8+/+.
(B) Heatmaps of genes with >2-foldmisexpression inSox2,Cyp19, and E2f7/;E2f8/ fetuses relative to E2f7+/+;E2f8+/+ fetuses (p < 0.05). n, number of fetuses
analyzed per genetic group.
(C) Scatterplot analyses of stress-related gene expression in the fetuses with indicated genetic groups using a 2-fold cutoff (red, >2-fold deregulation).
(D) Quantification of apoptotic (TUNEL-positive) cells in E10.5 fetal tissues. E2f7/E2f8/ (red) (previously published in Li et al., 2008, included here for
comparison); Sox2-cre;E2f7loxp/-;E2f8loxp/- (blue);Cyp19-cre; E2f7loxp/loxp;E2f8loxp/loxp (yellow); littermate controls (black) were E2f7+/+E2f8+/+, E2f7loxp/-;E2f8loxp/-,
or E2f7loxp/loxp;E2f8loxp/loxp, respectively (**p < 0.02). Data are reported as the average ± SD of percentage of positive cells.
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E2F Activation and Repression in Developmentevery embryonic stage analyzed, including at birth (Figures 7K
and S5C). Together, these findings suggest that E2F3a is a key
modulator that antagonizes E2F7- and E2F8-mediated repres-
sion through activation of the same transcriptional program,
which is critical for placental development.
DISCUSSION
The atypical repressors E2F7 and E2F8 form the most ancient
arm of the E2F family of transcription factors. The classic repres-
sors E2F4–E2F6, unlike E2F7 and E2F8, associate with pocket
proteins and dimerization proteins (DP1/DP2) and are widely
viewed as the major E2F repressive arm that drives cell-cycle
exit and differentiation. In this study, we demonstrate that the
function of atypical repressors in extraembryonic tissues is
essential for repressing a broad spectrum of E2F targets that
control trophoblast proliferation, placental development, and(G) ChIP assays confirming promoter occupancy by E2F7 and E2F8 in a subset o
tagged versions of wild-type E2F7 and E2F8 (wt), or DNA-binding mutant E2F7 a
performed using primers specific to the E2F binding sites in target gene promoters
downstream coding region (E2f1 ds). Data are reported as average ± SD fold ch
Deveembryonic viability. Importantly, these studies uncover a tran-
scriptional program that is coordinated by two opposing arms
of the E2F family, the activating E2Fs and the two atypical
E2Fs, and they highlight an unanticipated feed-forward
loop between these two arms to ensure orderly cell-cycle
progression.
The placenta is one physiological context that has provided
insightful clues into the functions of the Cdk-Rb-E2F pathway
in mammals (Geng et al., 2003; Kohn et al., 2003, 2004; Kozar
et al., 2004; Malumbres et al., 2004; Parisi et al., 2003; Wenzel
et al., 2007). For example, genetic ablation of p57KIP, p21CIP1,
Cyclin E1/E2, Rb, and DP1, has been shown to result in extraem-
bryonic defects that contribute to the lethality of mutant embryos
(Geng et al., 2003; Kohn et al., 2004; Wenzel et al., 2007).
Previous work from our lab demonstrated that the targeted
disruption of E2f7 and E2f8 in mice leads to lethality by embry-
onic age 11.5, and consistent with their high expression inf the 16 potential E2F targets from E. HEK293 cells overexpressing either flag-
nd E2F8 (m) were used. Quantitative RT-PCR (normalized to 1% of input) was
as well as to irrelevant sequences in the tubulin promoter (Tub) and in the E2f1
ange.
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Figure 7. Loss of E2f3a Rescues Placental Defects and Fetal Apoptosis and Prolongs Viability of E2f7–/–E2f8–/– Embryos
(A) Quantitative RT-PCR of E2f3a mRNA levels in E10.5 E2f7+/+;E2f8+/+ (7+/+8+/+; n = 2) and E2f7/;E2f8/ (7/8/; n = 2) placentas (left) and western blot
analyses of lysates from E10.5 E2f7+/+;E2f8+/+ (7+/+8+/+) and E2f7/;E2f8/ (7/8/) placentas (right).
(B) ChIP assays using cell lysates from proliferating E2f7+/+;E2f8+/+ (black) and E2f7/;E2f8/ (red)mouse embryonic fibroblasts using antibodies against E2F3a
(3a), total E2F3 (3ab) and normal rabbit IgG (IgG). Quantitive PCR (normalized to 1% of input) was performed with primers flanking the E2F binding sites on the
indicated promoters.
(C) Heat maps of genes with >2-fold misexpression in E2f7/;E2f8/ (7/8/), E2f3a/ (3a/), or E2f7/;E2f8/;E2f3a/ (7/8/3a/) placentas
relative to E2f7+/+;E2f8+/+ (7+/+8+/+) counterparts (p < 0.05).
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exhibit severe placental abnormalities. Using tissue-specific
gene-ablation strategies we identified disruption of E2F7 and
E2F8 functions in trophoblast progenitor cells of the placenta
as the likely underlying cause of lethality in E2f7/;E2f8/
embryos. Indeed, supplying mutant fetuses with a wild-type
placenta was sufficient to carry these embryos to birth and
beyond. It would thus appear that two parallel E2F regulatory
pathways, one dependent (E2F1–E2F3) and the other indepen-
dent (E2F7 and E2F8) on the canonical Cdk-Rb-E2F axis, are
critically important in extraembryonic trophoblast lineages.
Thus, one reason for the increasing complexity of the metazoan
E2F gene family during evolution, from three E2Fs in worms and
two in flies to at least eight in mammals, may reflect divergent
cell-cycle requirements in extraembryonic versus fetal tissues
(van den Heuvel and Dyson, 2008; Winn et al., 2011).
Previous work showed that the early lethality of E2f7/;
E2f8/ embryos is accompanied by massive apoptosis
throughout the fetus. Data presented here demonstrate that
defective placental function contributes to fetal programmed
cell death. Additional genetic studies, however, showed that
the concomitant loss of E2f1 or p53 is able to suppress
apoptosis in multiple organs of E2f7/E2f8-deficient embryos,
but this occurs without correcting placental abnormalities or
extending fetal viability past E11.5 (unpublished data; Li et al.,
2008). Thus, cell autonomous mechanisms involving E2f1
and p53 and cell nonautonomous mechanisms resulting from
placental abnormalities both contribute to the massive ectopic
apoptosis observed in E2f7/;E2f8/ fetuses.
Elegant work in flies has demonstrated antagonistic roles for
dE2f1 and dE2f2 in the control of cell proliferation and larval
development (Ambrus et al., 2007; Cayirlioglu et al., 2003; Frolov
et al., 2001, 2003; Weng et al., 2003). While it was shown that in
some cases dE2F1 and dE2F2 regulate the same target genes
(including many cell-cycle regulatory genes) through activation
and repression, respectively, by and large these two fly E2Fs
regulate distinct sets of targets whose functions converge, in
ways not completely understood, on key developmental pro-
cesses (Cayirlioglu et al., 2003; Dimova et al., 2003; Stevaux
et al., 2005). It is generally viewed that mammalian activators
(E2F1–E2F3) and classic repressors (E2F4–E2F6) also work
together to orchestrate the expression of E2F target genes
during the cell cycle. However, surprisingly little evidence in vivo(D) Waterfall plot representing degree of gene-expression rescue in E2f7/;E2f8
E2f7/;E2f8/ placentas. Data are shown as the percentage change in average
relative to E2f7+/+;E2f8+/+ placentas. Three classes of targets are noted, with Cla
Class II representing genes that are rescued by 25%–75%, and Class III represe
(E) Quantitative RT-PCR confirmation of expression changes in a subset of genes
with the lowest expression was normalized to 1.
(F) Relative expression of E2f7 and E2f8 in E2f3a+/+ and E2f3a/ E10.5 whole pla
and the wild-type control sample with the lowest expression was normalized to
(G) Quantification of BrdU-positive cells in trophoblast giant cell (TGC) and sp
**p < 0.003).
(H) Representative low- and high-magnification H&E images of E10.5 placental
Labyrinth. Yellow dotted line demarks junctional zone from decidua.
(I) Scatterplot analyses of stress-related gene expression in the fetuses with indi
(J) Quantification of TUNEL-positive cells in the indicated tissues of E10.5 E2f7/
(K) Genotypic analysis of embryos derived from intercrosses of E2f7+/;E2f8+
development. For (A), (B), (E–G), and (J), data are reported as average ± SD.
Deveexists to support the notion that these two subsets of mamma-
lian E2Fs regulate the same set of target genes or even function
in the same tissues. Indeed, mice deficient for each E2F acti-
vator or canonical repressor display phenotypes with distinct
tissue involvement that are conspicuously devoid of major cell
cycle alterations (Chen et al., 2009; Chong et al., 2009b;
Cloud et al., 2002; Danielian et al., 2008; Field et al., 1996; Hum-
bert et al., 2000; Kinross et al., 2006; Li et al., 2003; Lindeman
et al., 1998; Murga et al., 2001; Pohlers et al., 2005; Rempel
et al., 2000; Yamasaki et al., 1996). While redundant functions
among family members may explain the absence of clear-cut
cell-cycle-related phenotypes in these mice, it is possible and
perhaps likely that the expected outcomes were overly reliant
on previous results obtained from cell-culture systems. We
show here that a single activator (E2F3a) and the two atypical
repressors (E2F7 and E2F8) are utilized in vivo to coregulate
cell proliferation. Using systematic analyses of global gene
expression profiles and biochemical approaches, we demon-
strate that E2F7 and E2F8 directly repress a subset of G1-S
genes that control S-phase entry in trophoblast lineages.
Surprisingly, microarray gene expression analysis of E2f3a-
deficient placentas revealed a significant decrease in most of
these same target genes. This observation is remarkable given
the divergent nature of their DNA-binding domains, with E2F3a
utilizing intermolecular interactions with its partner protein DP
(Zheng et al., 1999) and E2F7/E2F8 utilizing both inter- and intra-
molecular interactions between its two DNA-binding domains
(Di Stefano et al., 2003; Logan et al., 2005; Maiti et al., 2005).
The fact that expression of target genes in E2f7, E2f8, and
E2f3a triple-deficient placentas was partially or completely
restored to wild-type levels, and even more surprising that these
mutant embryos now survived to term, suggests that these three
E2Fs coordinately regulate the expression of genes that are
physiologically meaningful for embryonic development.
But how might these two arms of E2Fs coregulate gene
expression in vivo? Two possibilities may be ruled out based
on key observations. First, bioinformatics analysis of target
promoter sequences identified here shows that most targets
only have a single E2F consensus binding site, and therefore
activators and atypical repressors are unlikely to simultaneously
bind and coregulate these target promoters. Second, competi-
tive binding of E2F activators and repressors to the same
consensus sequences is also unlikely, since the expression/;E2f3a/ placentas for 285 genes (>2-fold, p < 0.05) that are deregulated in
expression between E2f7/;E2f8/;E2f3a/ and E2f7/;E2f8/ placentas
ss I representing genes that are rescued by >75% relative to wild-type levels,
nting genes that are rescued by <25%.
in (D). Values are normalized to Gapdh levels and the wild-type control sample
centas by quantitative RT-PCR assays. Values are normalized to Gapdh levels
1.
ongiotrophoblast cell (ST) lineages with the indicated genotypes (*p < 0.02,
tissues with the indicated genotypes. Scale bars, 100 mm. De., Decidua; La.,
cated genetic groups using a 2-fold cutoff (red, >2-fold deregulation).
;E2f8/E2f3a/, E2f7/;E2f8/, and E2f7+/+;E2f8+/+ fetuses (**p < 0.003).
/;E2f3a+/ and/or E2f7+/;E2f8/;E2f3a+/ mice at the indicated stages of
lopmental Cell 22, 849–862, April 17, 2012 ª2012 Elsevier Inc. 859
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by the genetic inactivation of E2f7 and E2f8. Several clues
suggest instead that the basis for how E2F3a and E2F7/E2F8
proteins coordinate gene expression is dependent on their
temporal occupancy on target promoters during the cell cycle.
Studies performed in multiple cell lines have shown that E2F3a
protein levels peak at G1-S, followed by a precipitous drop in
early to mid-S phase (Ishida et al., 2001; Leone et al., 1998). In
contrast, levels of E2F7 and E2F8 begin to increase in mid- to
late S phase, peak in G2 and decline as cells approach M and
the next G1 phase (de Bruin et al., 2003; Maiti et al., 2005). The
cell-cycle-dependent accumulation of E2F7 and E2F8 proteins
in cell lines is consistent with our IHC of placentas showing
that 30% of trophoblast nuclei stain strongly positive for these
two proteins at any given time point. The sequential accumula-
tion of E2F3a followed by E2F7/E2F8 proteins during the cell
cycle is likely no coincidence, since we show here that loss of
E2f3a leads to a decrease in E2f7 and E2f8 expression. These
observations support a mechanism where the loading of
E2F3a on target promoters at G1-S leads to their activation,
including that of E2f7 and E2f8. As atypical E2F protein levels
increase in mid- to late S phase and E2F3a protein is targeted
for degradation (Leone et al., 1998), G1-S targets become
efficiently repressed by E2F7 and E2F8, leading to their decline
by G2-M. Thus, the E2F3a-dependent activation of E2f7 and
E2f8 may be viewed as a mechanism to ensure that rhythmic
waves of E2F-dependent activation and repression drive cell-
cycle-dependent gene expression. Whether E2F3a directly
activates E2f7 and E2f8 promoters is not yet clear but certainly
is an attractive possibility.
While not all questions have been answered, it is certain from
our analyses of single-, double-, and triple-knockout mice that
activator and atypical repressor arms of the E2F program coor-
dinately regulate cell-cycle-dependent gene expression in vivo,
and that this has a profound impact on cell proliferation and
embryonic development. We thus suggest a paradigm for how
E2F targets are regulated, which contrary to current belief
does not generally involve classical E2F repressors but rather
involves repression by the most ancient and ironically termed
‘‘atypical’’ E2Fs. In this view, cell-cycle-dependent gene expres-
sion requires the balanced and timely interplay between
Rb-regulated E2F activators and Rb-independent atypical
repressors.
EXPERIMENTAL PROCEDURES
Mouse Strains and Genotyping
All protocols involving mice were approved by the Institutional Animal Care
and Use Committee at The Ohio State University. Transgenic mice used
for this study were maintained in a mixed 129SvEv;C57BL/6;FVB back-
ground. Allele-specific (E2f7/8, Rosa26, Plf Cre, and Pl1Cre) and transgene-
specific primers (Sox2-cre and Cyp19-cre) were used for PCR genotyping
(Hayashi et al., 2002; Li et al., 2008; Soriano, 1999; Wenzel and Leone,
2007; unpublished data). Laser Capture Microdissections were done at the
Laser Capture Molecular Core, The Ohio State University Medical Center
(https://lcm.osu.edu/).
Histology, Immunostaining, and Quantification
Standard protocols were used for preparation of 5-mm-thick paraffin-
embedded sections of placentas and for hematoxylin and eosin staining. For
immunohistochemistry, primary antibodies against E2F7 (ab56022, Abcam),860 Developmental Cell 22, 849–862, April 17, 2012 ª2012 Elsevier IE2F8 (custom-made polyclonal antibody raised against a peptide represent-
ing amino acids 576–595 of murine E2F8, Quality Controlled Biochemicals),
Esx1 (sc-133566, Santa Cruz), P-H3 (06-570, Millipore), BrdU (MO-0744,
DAKO), TTF-1 (sc-13040, Santa Cruz), CC10 (sc-25555, Santa Cruz), and
PL-1 (a gift from Dr. F. Talamantes) were used. Pregnant mice at 10.5 days
postcoitum were given intraperitoneal injections of BrdU (100 mg/g of body
weight) 30 min prior to harvesting. Detection of primary antibodies was done
using species-specific biotinylated secondary antibodies along with Vectas-
tain Elite ABC reagent (Vector labs) and DAB peroxidase substrate kit (Vector
labs) or fluorophore (Alexa Fluor, Invitrogen) conjugated secondary antibodies.
Nuclear counterstaining was done using either hematoxylin or DAPI. Apoptotic
cells were detected using TUNEL (S7101, Millipore) assays, performed
according to the manufacturer’s protocol. Images of immunostained sections
were captured using Eclipse 50i (Nikon) and Axioskop 40 (Zeiss) microscopes
and positive cells were quantified using Metamorph Imaging 6.1 software.
Three sections per sample and at least three different samples for each geno-
type were analyzed. Data are reported as the average ± SD of the percentage
of positive cells.
Quantitative RT-PCR
Total RNA was extracted using QIAGEN RNA miniprep columns with in-
column DNase treatment according to the manufacturer’s protocol. Reverse
transcription of total RNA was performed using Superscript III reverse
transcriptase (Invitrogen) and RNase inhibitor (Roche) as described by the
manufacturer. Quantitative PCR was performed using SYBR Green reaction
mix (BioRad) and the BioRad iCycler PCR machine. All reactions were per-
formed in triplicate and relative amounts of cDNA were normalized to Gapdh.
Data are reported as the average ± SD fold induction.
In Situ Hybridization
In situ hybridization was performed on E9.5 (Proliferin) and E10.5 (Tpbp)
placenta sections using a previously reported protocol (Christensen et al.,
2002) modified (deparaffinization in xylene and proteinase K digestion) for
paraffin-embedded sections. Plasmids for Proliferin and Tpbp (gifts from
Dr. J. Rossant) were linearized with HindIII and XbaI, respectively, to generate
templates for riboprobe synthesis. Hybridizations were performed with 1 3
107 dpm/slide of radiolabeled probes generated by in vitro transcription
with either T7 (Proliferin) or T3 (Tpbp) RNA polymerase (Roche) using both
35S-CTP and 35S-UTP. Autoradiography emulsion NTB (Kodak) was applied
to the slides and the emulsion was exposed for 1 day (Proliferin) or 3 days
(Tpbp) before being developed.
Affymetrix Microarray Analysis
Total RNA was isolated using QIAGEN RNA miniprep columns according to
the manufacturer’s protocol. Global gene expression analyses were per-
formed on Affymetrix Mouse Genome 430 2.0 arrays at the Ohio State Univer-
sity Comprehensive Cancer Center (http://www.osuccc.osu.edu/microarray/).
Expression values were adjusted by quantile normalization and log2 transfor-
mation with RMAExpress and were analyzed using BRB-ArrayTools 3.7.0
(http://linus.nci.nih.gov/BRB-ArrayTools.html). Class comparison was used
to select genes differentially expressed at a significance level of p < 0.05.
Probes with a >2-fold misexpression in E2f7/;E2f8/ when compared to
E2f7+/+;E2f8+/+ were used, and the average relative expression level of each
genetic group was used to generate heatmaps. Clustering and scatterplot
analyses were performed by using functions of BRB Array Tools. Promoter
sequences of each gene (1000 bp to +300 bp relative to transcriptional start
site) were obtained from UCSC genome browser (http://genome.ucsc.edu/).
TFSearch (http://www.cbrc.jp/research/db/TFSEARCH.html) aided in the
identification of genes containing E2F consensus binding sites (Heinemeyer
et al., 1998).
Chromatin Immunoprecipitation
The EZ ChIP assay kit (Upstate Biotech) was used as described by the manu-
facturer. Primary antibodies used were anti-flag (M2, Sigma) and normal
mouse IgG (Oncogene) antibodies (E2F7 and E2F8 ChIP) or anti-E2F3a
(N-20, Santa Cruz), anti-E2F3 (C-18, Santa Cruz), and normal rabbit IgG
(Oncogene) (E2F3a ChIP). Quantitive PCR was performed on decrosslinked
and column-purified (Qiaquick, QIAGEN) DNA fractions using the Bio-Radnc.
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Reactions were performed in triplicate and normalized using the threshold
cycle number for the 1% of total input sample. Data are reported as the
average ± SD fold change.
Statistical Analysis
Pairwise comparisons of quantifications from histology and immunohisto-
chemistry samples were evaluated by two-tailed Student’s t test. Statistical
analysis of viability of embryos harvested from timed pregnancies was done
by Fisher’s exact test.
ACCESSION NUMBERS
The microarray data are available in the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/gds) under the accession number
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